Merck's lung cancer drug poses unacceptable safety risks to patients

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Cancer treatment, oncology drug access, hematologic malignancies, and cancer drug policy.

Specific solid tumor cancer types organized by organ system and tissue origin.

Cancer treatment modalities including targeted therapy, immunotherapy, biologic therapies, and AI-driven treatment approaches.

Monitoring and prevention of adverse effects from medications.

Cancer screening, immunotherapy, CAR-T therapies, targeted drugs, biomarkers, and AI in oncology.